Dr Damien Kee
Honorary (Fellow)
Department of Medical Biology (WEHI)
116 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
HER2 mutations in advanced NSCLC: Prevalence, mutational context, and clinical outcomes from an Australian clinico-genomic database.
DOI: 10.1200/jco.2026.44.16_suppl.e206732026
Journal article
Real world outcomes of neoadjuvant immune checkpoint blockade (ICB) for resectable stage III melanoma: Pathologic response and FDG PET/CT correlates.
DOI: 10.1200/jco.2026.44.16_suppl.95692026
Journal article
Genomic Therapy Matching in Rare and Refractory Cancers
DOI: 10.1001/jamaoncol.2026.01272026
Journal article
Translating ctDNA into cutaneous melanoma care: An international expert survey
DOI: 10.1016/j.ejca.2026.1166762026
Journal article
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial.
DOI: 10.1158/1078-0432.CCR-25-40092026
Journal article
Nivolumab and Ipilimumab in Advanced Mismatch Repair–Deficient/Microsatellite Instability–High Noncolorectal Cancers: A Nonrandomized Clinical Trial
DOI: 10.1001/jamaoncol.2025.47212023
Research grants (ARC, NHMRC, MRFF)
Using Real World Data to Drive Cancer Care Research and Delivery
RECENT SCHOLARLY WORKS
2026
Journal article
Systemic Surveillance Guidelines for Uveal Melanoma: A Systematic Review
DOI: 10.1111/ceo.700022026
Journal article
An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial
DOI: 10.1038/s41591-026-04518-z2025
Journal article
797P Real-world experience of liquid biopsy (LBx) vs tissue-based comprehensive genomic profiling (tCGP)
DOI: 10.1016/j.annonc.2025.10.12112025
Journal article
768P Operational challenges of molecular tumour board (MTBs) in the Australasian public healthcare services: A scoping survey to inform the future of precision oncology
DOI: 10.1016/j.annonc.2025.10.1183